Multi-drug DDS

Dispersion-based production of multi-drug DDS for HCC chemoimmunotherapy

Here we aim to improve the pharmacokinetic properties of anti-cancer drug delivery vehicles, by producing all-prodrug nanoparticles with defined compositions of active agents. The therapeutic nanoparticles are designed for hepatocellular carcinomas.

Contact
Associated Scientist, Ulm University

Prof. Dr. Alexander Kühne

T
+49 731 50 22870
Show the email